These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2785820)
21. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Post RM; DeLisi LE; Holcomb HH; Uhde TW; Cohen R; Buchsbaum MS Biol Psychiatry; 1987 May; 22(5):545-53. PubMed ID: 3495297 [TBL] [Abstract][Full Text] [Related]
22. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. al-Mousawi AH; Evans N; Ebmeier KP; Roeda D; Chaloner F; Ashcroft GW Br J Psychiatry; 1996 Oct; 169(4):509-16. PubMed ID: 8894204 [TBL] [Abstract][Full Text] [Related]
23. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia. Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838 [TBL] [Abstract][Full Text] [Related]
24. Regional metabolism in microsmic patients with schizophrenia. Clark C; Kopala L; Hurwitz T; Li D Can J Psychiatry; 1991 Nov; 36(9):645-50. PubMed ID: 1685350 [TBL] [Abstract][Full Text] [Related]
25. Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia. Gordon E; Barry RJ; Anderson J; Fawdry R; Yong C; Grunewald S; Meares RA Aust N Z J Psychiatry; 1994 Sep; 28(3):446-52. PubMed ID: 7893239 [TBL] [Abstract][Full Text] [Related]
26. Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology. Wolkin A; Sanfilipo M; Angrist B; Duncan E; Wieland S; Wolf AP; Brodie JD; Cooper TB; Laska E; Rotrosen JP Biol Psychiatry; 1994 Sep; 36(5):317-25. PubMed ID: 7993958 [TBL] [Abstract][Full Text] [Related]
27. Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals. Buchsbaum MS; Holcomb HH; Johnson J; King AC; Kessler R Hum Neurobiol; 1983; 2(1):35-8. PubMed ID: 6603452 [TBL] [Abstract][Full Text] [Related]
28. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Siegel BV; Nuechterlein KH; Abel L; Wu JC; Buchsbaum MS Schizophr Res; 1995 Sep; 17(1):85-94. PubMed ID: 8541254 [TBL] [Abstract][Full Text] [Related]
29. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia. Guich SM; Buchsbaum MS; Burgwald L; Wu J; Haier R; Asarnow R; Nuechterlein K; Potkin S Schizophr Res; 1989; 2(6):439-48. PubMed ID: 2487185 [TBL] [Abstract][Full Text] [Related]
30. Regional cerebral glucose metabolism in three sets of identical twins with psychotic symptoms. Clark C; Klonoff H; Tyhurst JS; Li D; Martin W; Pate BD Can J Psychiatry; 1989 May; 34(4):263-70. PubMed ID: 2786742 [TBL] [Abstract][Full Text] [Related]
31. Regional cerebral glucose metabolism in major depressive disorder. Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619 [TBL] [Abstract][Full Text] [Related]
32. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Goffinet AM; De Volder AG; Gillain C; Rectem D; Bol A; Michel C; Cogneau M; Labar D; Laterre C Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043 [TBL] [Abstract][Full Text] [Related]
38. Effect of sertraline on regional metabolic rate in patients with affective disorder. Buchsbaum MS; Wu J; Siegel BV; Hackett E; Trenary M; Abel L; Reynolds C Biol Psychiatry; 1997 Jan; 41(1):15-22. PubMed ID: 8988791 [TBL] [Abstract][Full Text] [Related]
39. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264 [TBL] [Abstract][Full Text] [Related]